| miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1 Y Liu, R Liu, F Yang, R Cheng, X Chen, S Cui, Y Gu, W Sun, C You, Z Liu, ... Molecular cancer 16, 1-17, 2017 | 177 | 2017 |
| The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer Y Liu, X Chen, R Cheng, F Yang, M Yu, C Wang, S Cui, Y Hong, H Liang, ... Molecular cancer 17, 1-15, 2018 | 125 | 2018 |
| miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4 Y Liu, Y Guo, H Liang, R Cheng, F Yang, Y Hong, C Zhao, M Liu, M Yu, ... Protein & cell 7 (10), 722-734, 2016 | 65 | 2016 |
| Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47 H Hu, R Cheng, Y Wang, X Wang, J Wu, Y Kong, S Zhan, Z Zhou, H Zhu, ... The Journal of Clinical Investigation 133 (2), 2023 | 57 | 2023 |
| A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers R Cheng, F Li, M Zhang, X Xia, J Wu, X Gao, H Zhou, Z Zhang, N Huang, ... Cell Research 33 (1), 30-45, 2023 | 40 | 2023 |
| miR‐129‐5p and‐3p co‐target WWP1 to suppress gastric cancer proliferation and migration L Ma, X Chen, C Li, R Cheng, Z Gao, X Meng, C Sun, C Liang, Y Liu Journal of Cellular Biochemistry 120 (5), 7527-7538, 2019 | 32 | 2019 |
| Design, synthesis, and evaluation of 4 (1H)-quinolinone and urea derivatives as KRASG12C inhibitors with potent antitumor activity against KRAS-mutant non-small cell lung cancer R Cheng, X Lv, H Bu, Q Xu, J Wu, K Xie, J Tang, L Wang, J Zhuang, ... European Journal of Medicinal Chemistry 244, 114808, 2022 | 7 | 2022 |
